We bring you the latest news from the healthcare about the health care in the United Kingdom.

donderdag 25 oktober 2018

Oncogene - Table of Contents alert Volume 37 Issue 43



Volume 37, Issue 43

In this issue
Also new


Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer

Rachel Brough, Aditi Gulati, Syed Haider, Rahul Kumar, James Campbell et al.

Oncogene 2018 37 :5701 - 5718; June 18, 2018; 10.1038/s41388-018-0368-z

Abstract | Full Text

The dimer-dependent catalytic activity of RAF family kinases is revealed through characterizing their oncogenic mutants

Jimin Yuan, Wan Hwa Ng, Paula Y. P. Lam, Yu Wang, Hongping Xia et al.

Oncogene 2018 37 :5719 - 5734; June 21, 2018; 10.1038/s41388-018-0365-2

Abstract | Full Text

PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein

Minggang Peng, Jingjing Wang, Dongyun Zhang, Honglei Jin, Jingxia Li et al.

Oncogene 2018 37 :5735 - 5748; June 21, 2018; 10.1038/s41388-018-0374-1

Abstract | Full Text

MacroH2A1.2 inhibits prostate cancer-induced osteoclastogenesis through cooperation with HP1α and H1.2

Jin-Man Kim, Yonghwan Shin, Sunyoung Lee, Mi Yeong Kim, Vasu Punj et al.

Oncogene 2018 37 :5749 - 5765; June 20, 2018; 10.1038/s41388-018-0356-3

Abstract | Full Text

The homeostasis-maintaining metabolites from bacterial stress response to bacteriophage infection suppress tumor metastasis

Tianliang He, Min Jin, Chenxi Xu, Zhongjun Ma, Fufang Wu et al.

Oncogene 2018 37 :5766 - 5779; June 20, 2018; 10.1038/s41388-018-0376-z

Abstract | Full Text

C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer

Mei-Chun Lin, Pin-Hui Chien, Hsin-Yi Wu, Syue-Ting Chen, Hsueh-Fen Juan et al.

Oncogene 2018 37 :5780 - 5793; June 21, 2018; 10.1038/s41388-018-0375-0

Abstract | Full Text

FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation

Yan-Hong Cui, Hyeonmi Kim, Minyoung Lee, Joo Mi Yi, Rae-Kwon Kim et al.

Oncogene 2018 37 :5794 - 5809; July 04, 2018; 10.1038/s41388-018-0372-3

Abstract | Full Text


Correction: Wild-type and mutated IDH1/2 enzymes and therapy responses

Remco J. Molenaar, Jaroslaw P. Maciejewski, Johanna W. Wilmink & Cornelis J. F. van Noorden

Oncogene 2018 37 :5810 - 5810; August 23, 2018; 10.1038/s41388-018-0455-1

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

This email has been sent to dezorgsector.uk@gmail.com.

If you no longer wish to receive the email alerts from Oncogene click here to unsubscribe .
If you wish to discontinue all email services from Nature Research please click here to unsubscribe .

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Research | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.

Springer Nature